🔎 Trials Near Me

Pradžia › Genetiniai sutrikimai › New York

Genetiniai sutrikimai klinikiniai tyrimai New York

7 tyrimai dėl Genetiniai sutrikimai ieško dalyvių vietose New York.

Miestai New York

Oficialus tyrimo tekstas (anglų kalba)

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

  • Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
7 Months – 15 Months · Visoms lytims · Atnaujinta 2026-08-31 · NCT06805695

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Jacobi Medical Center, The Bronx
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07224360

Helix Research Network

  • Rochester Regional Health (GenoWell), Rochester
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-23 · NCT06057181

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

  • Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviai1/2 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-03-23 · NCT05130437

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Renkami dalyviai3 fazė
Amžius nuo 12 iki 35 · Visoms lytims · Atnaujinta 2026-03-23 · NCT05477563

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • Icahn School of Medicine at Mount Sinai - Clinical Research Unit, New York
Renkami dalyviai1/2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-01-22 · NCT04159103

STXBP1 and SYNGAP1 Related Disorders Natural History Study

  • Weill Cornell Medicine, New York
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-29 · NCT06555965

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.